Page last updated: 2024-10-25

diazoxide and CHARGE Association

diazoxide has been researched along with CHARGE Association in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Research Excerpts

ExcerptRelevanceReference
"This case shows that patients with CHARGE syndrome caused by a CHD7 mutation may present with persistent hyperinsulinemic hypoglycemia, just like other dysmorphic syndromes genetically caused by aberrations in chromatin remodeling."1.48A case of CHARGE syndrome associated with hyperinsulinemic hypoglycemia in infancy. ( Fukami, M; Ihara, K; Itonaga, T; Maeda, T; Sekiguchi, K; Yorifuji, T, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekiguchi, K1
Itonaga, T1
Maeda, T1
Fukami, M1
Yorifuji, T1
Ihara, K1

Other Studies

1 other study available for diazoxide and CHARGE Association

ArticleYear
A case of CHARGE syndrome associated with hyperinsulinemic hypoglycemia in infancy.
    European journal of medical genetics, 2018, Volume: 61, Issue:6

    Topics: Alleles; Blood Glucose; CHARGE Syndrome; Chromatin Assembly and Disassembly; Congenital Hyperinsulin

2018